Alkermes
preclinical data demonstrated accumulation of tumor targeted split subunits in the tumor pet imaging of tumor hours post treatment single chain non targeted targeted subunit targeted subunit molecules in tumor high signal non targeted targeted targeted non targeted targeted low signal alkermes internal data on file murine tumors in mice percent of injected dose per gram of tissue | Alkermes
Company
Deck Type
Sector
Industry
Deck date
March 2021
Slide
107 of 144
Related slides by other companies
MindMed
Investor Presentation
June 2023
preclinical data indicate potential enhanced benefit risk profile | MindMed
Getty
Investor Day
March 2022
data signals | Getty
MindMed
Investor Presentation
September 2023
preclinical data indicate potential enhanced benefit risk profile | MindMed
MindMed
Investor Presentation
August 2023
preclinical data indicate potential enhanced benefit risk profile | MindMed
Other recent decks by Alkermes
See all presentations (22 decks)
Investor Conference
January 2024
Results
October 2023
Investor Presentation
October 2023
Results
July 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io